Hsiao-Ling Chen Selected Research

Catheters

2/2022	Short time to positivity of blood culture predicts mortality and septic shock in bacteremic patients: a systematic review and meta-analysis.
2/2019	Risk factors associated with outcomes of peritoneal dialysis in Taiwan: An analysis using a competing risk model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hsiao-Ling Chen Research Topics

Disease

13	Neoplasms (Cancer) 08/2019 - 03/2008
11	Inflammation (Inflammations) 08/2021 - 04/2013
9	Body Weight (Weight, Body) 01/2018 - 02/2003
8	Fibrosis (Cirrhosis) 08/2021 - 04/2011
5	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2013
5	Lung Injury 01/2020 - 01/2011
5	Hyperoxia 01/2020 - 01/2011
4	Infections 02/2022 - 02/2008
4	Osteoporosis 11/2020 - 10/2011
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014 - 04/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 04/2021
3	Diabetes Mellitus 04/2022 - 02/2019
3	Carcinoma (Carcinomatosis) 03/2021 - 01/2015
3	Hypertension (High Blood Pressure) 01/2021 - 10/2014
3	Atrophy 08/2020 - 01/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2015 - 03/2008
3	Carcinogenesis 01/2013 - 02/2011
2	Stroke (Strokes) 04/2022 - 08/2020
2	Neoplasm Metastasis (Metastasis) 04/2021 - 08/2019
2	Squamous Cell Carcinoma of Head and Neck 08/2019 - 01/2014
2	Pneumonia (Pneumonitis) 01/2019 - 01/2013
2	Asthma (Bronchial Asthma) 01/2018 - 06/2013
2	Alzheimer Disease (Alzheimer's Disease) 05/2017 - 06/2012
2	Diarrhea 10/2014 - 01/2004
2	Respiratory Insufficiency (Respiratory Failure) 10/2014 - 01/2011
2	Adenocarcinoma of Lung 01/2014 - 01/2013
2	Muscle Spasticity (Spastic) 01/2013 - 01/2013
2	Liver Neoplasms (Liver Cancer) 01/2013 - 03/2008
2	Colonic Neoplasms (Colon Cancer) 09/2010 - 10/2007
1	Thrombosis (Thrombus) 04/2022
1	Myocardial Infarction 04/2022
1	Hemorrhage 04/2022
1	Sepsis (Septicemia) 02/2022
1	Septic Shock (Toxic Shock Syndrome) 02/2022
1	Malignant Mesothelioma 12/2021
1	Dysbiosis 08/2021
1	Cataract (Cataracts) 08/2021

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2008
9	LactoferrinIBA 01/2020 - 01/2004
6	CollagenIBA 08/2021 - 04/2011
6	AntioxidantsIBA 08/2020 - 08/2011
6	Messenger RNA (mRNA)IBA 01/2015 - 04/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2011
5	Therapeutic UsesIBA 01/2018 - 01/2011
4	(1-6)-alpha-glucomannan (glucomannan)IBA 01/2021 - 11/2006
4	Peptides (Polypeptides)IBA 08/2020 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 10/2006
3	Volatile Fatty AcidsIBA 01/2021 - 09/2010
3	Inulin FDA Link 01/2021 - 10/2007
3	Superoxide DismutaseIBA 08/2020 - 01/2011
3	LuciferasesIBA 01/2020 - 10/2014
3	AllergensIBA 01/2018 - 06/2013
3	Tocopherols (Tocopherol)IBA 05/2017 - 06/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2015 - 04/2013
3	CytokinesIBA 10/2014 - 01/2013
3	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2013 - 04/2011
2	Pemetrexed (MTA)FDA Link 12/2021 - 07/2003
2	PlatinumIBA 12/2021 - 12/2020
2	Anaplastic Lymphoma KinaseIBA 09/2021 - 04/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021 - 01/2013
2	MyostatinIBA 06/2019 - 02/2016
2	CreatinineIBA 02/2019 - 01/2019
2	AlbuminsIBA 01/2019 - 01/2011
2	Galactose (Galactopyranose)FDA LinkGeneric 05/2017 - 06/2012
2	Vitamin E FDA LinkGeneric 05/2017 - 03/2011
2	Botulinum Toxins (Botulinum Toxin)IBA 02/2016 - 01/2013
2	AerosolsIBA 10/2014 - 01/2011
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2014 - 01/2013
2	Cyclin BIBA 01/2013 - 01/2013
2	Cyclin AIBA 01/2013 - 01/2013
2	Glutamic Acid (Glutamate)FDA Link 08/2012 - 04/2011
2	Transaminases (Aminotransferases)IBA 08/2012 - 04/2011
2	Alanine Transaminase (SGPT)IBA 08/2012 - 04/2011
2	Oxaloacetic Acid (Oxalacetic Acid)IBA 08/2012 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 06/2012 - 01/2011
2	Bile Acids and Salts (Bile Acids)IBA 02/2011 - 09/2010
2	CelluloseIBA 09/2010 - 10/2007
2	VaccinesIBA 06/2008 - 02/2008
1	ErbB Receptors (EGF Receptor)IBA 06/2022
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2022
1	thiamine triphosphorate (TTP)IBA 02/2022
1	Fibronectins (Fibronectin)IBA 08/2021
1	EndotoxinsIBA 08/2021
1	Cisplatin (Platino)FDA LinkGeneric 08/2021
1	IndicanIBA 08/2021
1	Butyric Acid (Butanoic Acid)IBA 08/2021
1	ORALIT (ORS)IBA 08/2021
1	CholesterolIBA 08/2021
1	lorlatinibIBA 04/2021
1	alectinibIBA 04/2021
1	abirateroneIBA 01/2021

Therapy/Procedure

13	Therapeutics 04/2022 - 03/2008
4	Drug Therapy (Chemotherapy) 06/2022 - 12/2020
4	Oral Administration 01/2020 - 04/2013
2	Catheters 02/2022 - 02/2019
2	Intraperitoneal Injections 01/2018 - 08/2015
1	Percutaneous Coronary Intervention 04/2022
1	Stents 04/2022
1	Salvage Therapy 12/2021